Abbott's adjusted diluted EPS payout ratio is going to expand significantly from the mid-30% range in 2022 to the mid-40% range in 2023. Reduced demand for COVID-19 testing saw the healthcare company'
Abbott Laboratories and AbbVie used to be one and the same company. Both have raised their payouts for 51 years in a row, making them Dividend Kings.
For an investment to reach $1 million, you need to consider how much you're willing to invest and for how long. Abbott Laboratories is a top healthcare company that has grown to a valuation of nearly
India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing license of its popular antacid medicine after inspectors flagged contamination risks and saniti

Is Abbott Laboratories a Buy?

09:45am, Tuesday, 12'th Sep 2023
Abbott Laboratories isn't a rapidly growing stock. But the steady growth of its dividend can add up over time.
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
With inflation taking center stage once again, it's becoming clear that consumers are prioritizing wants and needs. One of those “non-discretionary” expenses is healthcare, which makes it a good t
The pharmaceutical sector will always be a sector in constant evolution and growth. As technology advances, the companies that make life in this sector will always be applying it, as well as implement
Abbott's (ABT) recent deal will enable it to create more interconnected solutions to improve the personalization and accuracy of diabetes control.
There is more to the comparison, and in the sections below, we discuss why we believe that TMO will offer better returns than ABT in the next three years.
Shares of Abbott Laboratories have fallen by more than 10% from the high point they reached in July. The company has a remarkable track record of 50 consecutive years of annual dividend raises.
Abbott's (ABT) latest late-breaking data reflects OCT's potential to improve clinical practice related to stent placement.
Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the growing pharmaceutical markets.
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Fear is back in the air. On August 8, 2023, Moody's rating agency downgraded central U.S. banks due to weaker profits and increased funding risks.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE